Deeper dives into the data are available to AdComplyRx customers now and will be available more broadly soon. DM or email your #adcomplyrx rep for details. https://t.co/C7cDC6P9XT #StopHateForProfit#pharma#facebook
When your brand inadvertently runs non-compliant ads, are you creating a "control plan" to monitor and prevent recurrence? #FDA#OPDP https://t.co/Bijody9WKs
.@ComplyAd now examines Search interest among consumers in various disease states during COVID-19 as well pharma's adjustments to their patient advertising & messaging as the trajectory of this pandemic progressed. #SEM#VirtualDTCN https://t.co/ByRHtsvyCl
@PharmerRob What is the full cost of an FDA Warning Letter?
AdComplyRx data reveals PROCENTRA's #SEM campaign on #Google continues to be dark ever since their #OPDP#FDA Warning Letter in Feb - so going on 3 months without what was likely their top traffic driver #adcomplyrx
watching @deskakoff of @sharecare present at DTC National Virtual - May Event “telemedicine and relaxation/breathing exercises” are top health info needs among patients with chronic conditions #COVID19#pharma#sem
Compliance expert, Michael Shaw, shares how tools like CRM Approved Notes enables field reps to focus on business impact while avoiding risks. Register for #VeevaSummitOnline: https://t.co/2fO8pq33Fh #pharma#lifesciences